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Abstract
The relation between disease and urine was recognized by physicians since the 
earliest civilization BC. Urine is considered an ideal diagnostic specimen for its 
noninvasive and easy method of collection. Urinalysis encompasses a wide range 
of tests, which includes a variety of chemical tests, urine microscopy, bacterial 
cultures, and molecular tests. Importantly, urine tests can diagnose patients with 
antibiotic-resistant urinary tract infections (UTI), directly from urine and/or bacte-
rial culture. This chapter summarizes the most common urine tests in the infectious 
disease field, with a special focus on diagnosing UTI and characterizing their 
antibiotic resistant. In addition to describing the advantages and limitation of these 
tests, the chapter explores the promising emerging technologies and methods in this 
field. This chapter is beneficial for scientists and healthcare workers in the field.
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1. Introduction
Urinalysis has been a useful diagnostic tool since thousands of years. Although 
urine was the first body fluid to be examined by mankind for the diagnosis of 
diseases [1], it is still one of the most common specimens used in clinical and 
diagnostic laboratories. Urine samples have been used for the diagnosis of a wide 
and diverse range of disorders, including but not limited to renal diseases [2, 3], 
metabolic disorders [4], cancer [5], infectious diseases [6], and others [7–10].
In infectious disease field, urine tests are applied in diagnosing urinary tract 
infections (UTI) [11–13]. Further, several other infections can be diagnosed by 
urine tests at different levels [14] including community-acquired pneumonia (CAP) 
[15], legionellosis [16], tuberculosis [17, 18], congenital cytomegalovirus (CMV) 
infection [19], and dengue virus [20, 21], and recently, several papers suggest the 
high value of urinalysis in the detection of Zika virus [22, 23]. Parasites can also 
be diagnosed from the urine by detection of urinary egg, for example, diagnosis 
of Schistosoma haematobium (S. haematobium) [24]. Furthermore, urine has been 
used for screening of different sexually transmitted diseases (STD) such as Neisseria 
gonorrhoeae and Chlamydia sp. [25, 26]. The sensitivity and accuracy of urine test 
vary according to the agent being detected [14], and in some cases, urinalysis is only 
performed to exclude other diseases [27].
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Many of the aforementioned infections are treated with antimicrobial drugs 
[28–30], a discovery of the past century that completely changed the medical field 
and saved millions of lives [31]. Unfortunately, this discovery did not last unchal-
lenged for long; soon after the discovery of penicillin by Sir Alexander Fleming in 
1928 [32], the problem of penicillin resistance first emerged in 1947—19 years after 
its discovery and 4 years after the dug started being mass-produced and was used 
heavily to treat allied troops fighting in Europe during the World War II. Ever since, 
antimicrobial resistance (AMR) has become a fierce challenge endangering the 
existence of many antimicrobial agents [33].
With the emergence of pathogenic strains resistant to almost all available 
antimicrobial drugs [34, 35] and with only few new drugs in the development and 
production pipeline [36], AMR is now one of the most urgent global health threats 
[33]. This emphasizes on the importance of urine analysis and detection of antimi-
crobial resistance in the diagnostic laboratories.
Treatment of UTI is a good example of AMR impact on the medical field. 
Many of the antibiotics prescribed traditionally for the treatment of UTIs are now 
compromised and to a large extent are ineffective [37]. More alarming, recent years 
have recorded the emergence of bacterial strains that are resistant to even last resort 
antibiotics such as colistin, making the treatment of UTIs a global challenge [38].
2. Urine tests for infectious disease diagnostics and treatment
A urine specimen is one of the most frequent specimens examined in many of 
the clinical- and hospital-based laboratories. Urine cultures account for up to 40% 
of those laboratories’ cultures, making it the most common type of culture in such 
laboratories [27]. Urine is considered an ideal diagnostic specimen for its noninva-
sive, easy method of collection and the sufficient amount in which it is excreted [14].
The most common infections diagnosed by urinalysis are UTIs, which are one 
of the most common bacterial infections that require medical intervention. Several 
other infections such as community-acquired pneumonia and viremia infections 
can also be diagnosed with the help of urinalysis.
2.1 Urinalysis for diagnosis of urinary tract infection
UTI affects about 150 million around the globe every year [28]. Urinary tract 
infections are common in women and to less extent in children. Many women 
experience multiple infections during their lifetimes. Risk factors specific to women 
for UTIs include female anatomy. A woman has a shorter urethra than a man does, 
which shortens the distance that bacteria must travel to reach the bladder [39].UTIs 
are generally categorized clinically as complicated and uncomplicated based on the 
presence of risk factors that comprise the urinary tract or the host defense [40]. 
Both Gram-negative and Gram-positive bacteria can cause UTIs, with Escherichia 
coli representing about 40–70% of the cases [27].
The diagnosis of UTIs is mainly based on urinalysis and the medical history of 
the patient, with latter being the most essential element [27].
2.1.1 Sample collection
Avoiding contamination is a key element when collecting samples for diagnostic 
purposes. Bacterial contamination of the urine during collection is always a concern, 
and midstream urine is recommended for UTI. Clear instruction to the patient 
is indicated to reduce the risk of contamination with the use of clean containers. 
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Although methods such as suprapubic aspiration and straight catheter technique can 
reduce or even eliminate the chances of contamination, they are rarely performed as 
they are not practical for routine cases [27]. Importantly, these methods are invasive, 
costly, take a lot of time and effort, and are not risk free. Contamination and infec-
tion caused by the catheter used to collect the sample is one example [41]. One of the 
most common method used for the collection of urine is the clean-catch midstream 
technique [42], which is simple, noninvasive, and risk free and most importantly 
gives accurate enough results to be used for routine testing. Nonetheless, contamina-
tion of the sample is the main disadvantage of this method [43].
2.1.2 Sample processing
The clinical information obtained from a urine specimen is influenced by the 
collection method, timing, and handling. An enormous variety of collection and 
transport containers for urine specimens are available, depending on the type of labo-
ratory test ordered. National Committee for Clinical Laboratory Standards (NCCLS) 
recommended testing urine sample within 2 hours of collection to avoid false-positive 
results; however refrigeration or chemical preservation of urine specimens may 
be utilized if testing or refrigeration within a two-hour window is not possible. A 
variety of urine preservatives (tartaric and boric acids being the most common) are 
available that allow urine to be kept at room temperature while still providing results 
comparable to those of refrigerated urine. Generally, the length of preservation 
capacity ranges from 24 to 72 hours. Metabolites which can be significantly influenced 
by the interaction of exposure time and temperature include arginine, glutamine, 
methionine, phenylalanine, and others, while metabolites which can be significantly 
influenced by freeze and thaw cycles are the C3 family and histones H1 [44].
2.1.3 Urine microscopy
Bacteria can be simply observed in urine specimens under the microscope, espe-
cially after Gram staining. After centrifugation of urine samples, a small amount 
of the pellet is applied to a glass microscopic slide and stained with the usual 
Gram-staining protocol. Gram staining can also be done to uncentrifuged speci-
men; however, there are no definitive criteria to determine positive results with this 
method, and it is not sensitive for detection of low number of bacteria.
Although Gram-staining test can give relatively fast results about the nature of 
the causative agent; however it is not practical for routine use, it is labor intensive, 
insensitive test for concentration of bacteria lower than 105 cfu/mL, and time-
consuming, making it unsuitable for the patient with uncomplicated UTIs [45].
2.1.4 Urine nitrite test
Enterobacteriaceae are the main causative agent of UTI. They typically produce 
nitrite, thus making this bacterium chemically detectable. The urine sample for this 
test should be taken from the first urine produced in the morning, as a minimum 
of 4 hours are required for the bacteria to produce a detectable amount nitrite. 
Unfortunately, other bacteria such as Staphylococcus saprophyticus cannot produce 
nitrite, introducing limitation for this test. [46].
2.1.5 Pyuria
The presence of pus in the urine (i.e., pyuria) can be detected by various meth-
ods. The best and most accurate method is to microscopically measure the urinary 
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leukocyte excretion rate. Other microscopic methods may also include counting the 
leukocyte in the urine. However, as the microscopic method is unpractical for routine 
use, other easier methods such as leukocyte esterase tests for detection of pyuria can 
be performed. The leukocyte esterase tests have many disadvantages as it produces 
false-positive results due the presence of eosinophils in the urine. Decreased positive 
results or false-negative results of this test are referred to other reasons including 
elevated level of glucose and protein in the urine or if the patient is treated with 
certain drugs such as cephalexin or tetracycline [47]. The commercial products are 
believed to be more efficient, although they have low sensitivity, but they are highly 
specific, and they provide information about both pyuria and bacteriuria [27].
2.1.6 Urine culture
Urine culture is the gold standard in diagnosing UTI. It is crucial not only for the 
diagnosis but also to guide appropriate antimicrobial prescription and treatment. 
Patients with complicated UTIs, those who have suffered from recurrent UTIs, or 
those who are not responding to the empirical treatment are the ones usually subjected 
for urine culture. In this regard, the most common used culture media are the blood 
agar and MacConkey’s agar. This is especially true for specimen from outpatients, 
knowing that almost all UTIs in outpatients are caused by aerobic and facultative 
Gram-negative bacteria, making it unnecessary to use a medium that is selective for 
Gram-positive bacteria. However, for the hospitalized patients, inoculation of Gram-
positive bacteria especially cocci should be considered as enterococci is one of the most 
common causative agents of UTIs in inpatients. Thus, media routinely used should 
support growth of both Gram-negative and Gram-positive bacteria.
On the other hand, anaerobic bacteria are rarely a cause of UTIs, and cultures of 
anaerobic bacteria are usually indicated only for the patient with increased risk of 
infection with anaerobic bacteria, and those are usually patients with anatomical 
abnormalities.
For the diagnosis of Candiduria, blood agar which is used for routine bacterial 
culture can be used perfectly for its detection and other funguria.
2.2 Urinalysis for diagnosis of other infectious diseases
Many systemic infections other than UTIs can be diagnosed utilizing urine 
samples. This is applied for viral and bacterial infections. Some of the viruses are 
directly shed in urine such as human polyomaviruses and congenital cytomegalovi-
rus. Other infections can be detected by markers and antigen secretion in the urine. 
With the rapid development in diagnostic technologies, urine can be utilized to 
diagnose even a larger number of infectious agents.
2.2.1 Streptococcus pneumoniae
Streptococcus pneumoniae is the number one causative agent of community-
acquired pneumonia both in adult and children. In addition, it is underdiagnosed 
because of the lack of reliable and sensitive diagnostic method. CAP can be diag-
nosed using various samples including blood, sputum, and urine. Recently, multiple 
publications [48–50] provided evidence showing that urinalysis and urine specimen 
can be a very helpful in the diagnosis of CAP with relatively highly sensitive results. 
Urine immunoassay was used by reference laboratories to determine the course of 
a complicated outbreak of S. pneumoniae complicated by influenza A; this clearly 
indicates the importance of urine as a diagnostic specimen for the detection of S. 
pneumonia [51].
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2.2.2 Legionellosis
Legionella pneumophila is the most common cause of the life-threatening 
atypical pneumonia known as legionellosis or Legionnaires’ disease. Rapid urinary 
antigen detection kits are the primary choice for the diagnosis of legionellosis. It 
is considered to be a reliable diagnostic method for the detection of legionellosis 
with acceptable sensitivity. New tests and assays such as Legionella fluorescence 
immunoassay have been developed. And they seem promising with papers showing 
a higher sensitivity results [52].
2.2.3 Tuberculosis
Tuberculosis is a worldwide health issue. Many factors make tuberculosis hard to 
control, and one of them is the lack of fast and accurate diagnostic tools. With lipo-
arabinomannan (cell wall glycolipid of Mycobacterium tuberculosis) being secreted 
in the urine, several assays and tools have been developed to detect this marker of 
infection. However, no urine test until now is sensitive enough to be adopted for 
routine use [17, 18].
2.2.4 Human polyomaviruses
Infections with polyomaviruses with clinical significance occur generally only 
in immunocompromised patients; the virus is shed in urine in large quantities. The 
best way to detect the virus is by electronic microscopy, which is highly sensitive, 
although it is less sensitive than PCR; however, it might be more reliable clinically. 
That is because a large portion of the adult population are exposed to the virus, and 
PCR can give positive results to clinically insignificant cases [53].
2.2.5 Congenital cytomegalovirus
Congenital cytomegalovirus is the leading cause of neurological impairment 
and nongenetic sensorineural hearing loss. The virus can be cultured from urine 
and diagnosis can be made from various types of specimen which include urine, 
blood, and saliva [54]. PCR both quantitative and qualitative is widely used for 
diagnosis of CMV infection. Qualitative PCR test is intended to detect CMV DNA 
in urine, whereas quantitative PCR test is performed to detect quantitatively 
CMV DNA in urine specimens as an aid in identifying or management of CMV 
infections.
2.2.6 Dengue virus
Dengue virus is a mosquito-borne disease affecting more than 50 million people 
worldwide yearly. Urine specimen can be used for the early detection of this virus, 
although RT-PCR and ELISA along with other new methods all of which utilizing 
blood specimen are usually the way to detect dengue virus.
2.2.7 Zika virus
Zika virus is another mosquito-borne pathogen, and it is endemic to Africa and 
Southeast Asia. The detection of Zika virus can be achieved by ELISA, but it is usu-
ally detected by reverse transcription PCR (RT-PCR) from a serum sample. Some 
evidence shows that the virus can be detected from mother urine sample even after 
10 days of the onset of the disease, which is not feasible with serum samples.  
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This suggests that detection of Zika virus by real-time RT-PCR from urine specimen 
can be a valuable diagnostic tool [22].
2.2.8 Sexually transmitted disease
Urine specimen is of valuable importance in the diagnosis of sexually transmit-
ted diseases. Urinalysis can help in diagnosis of Mycoplasma genitalium, Chlamydia, 
Neisseria gonorrhoeae, Trichomonas vaginalis, and urethritis to name but a few. 
For example, leukocyte esterase dipstick test as a point-of-care diagnostic tool 
for urogenital Chlamydia, can be a valuable tool to accurately exclude Chlamydia. 
However, it shows low positive predictive value. Furthermore Chlamydia trachoma-
tis, Mycoplasma genitalium, and Neisseria gonorrhea can be detected with PCR and 
real-time duplex PCR from urine samples [55–58]. Using urine as a specimen for 
diagnosis of Gonococcal infections by molecular tests has eased out uncomfortable 
sample collection by urethral swab and hence increased the number of patients 
volunteering to give specimen for this disease of public health importance.
2.2.9 Parasite detection in urine
Urine microscopy and sediment test analysis help in the diagnosis of urinary 
parasites like Schistosoma urinary egg detection. However, egg detection method is 
below optimum and requires multiple samples; other methods for the detection 
of parasite in urine are being investigated. PCR shows promising results in this 
regards, and many papers are advocating for the clinical establishment of this 
method for detection of parasites such as S. haematobium, Leishmania infantum, 
Trypanosoma sp., and others [59–64].
2.3 New technologies and urinalysis
New technological advances have paved the way for significant progress in auto-
mated urinalysis [65]. Time and accuracy are the two key factors for diagnosis. In 
UTIs, urine dipsticks are very fast and easy to use, but it lacks the accuracy, whereas 
in the other hand, urine culture for antimicrobial susceptibility testing shows 
clinically reliable and accurate results, but it takes up to 3 days to give results. Many 
novel and improved diagnostic technologies and tools are introduced in the market, 
and some of them are already approved for clinical use and helped significantly in 
increasing the accuracy and decreasing the time of the test; a good example would 
be nucleic acid tests and mass spectrometry. Some other technologies show promis-
ing future such as the utilization of smartphone for urinalysis [65–68].
2.3.1 Flow cytometry
Recently flow cytometry is being introduced as a reliable method for fast diag-
nosis of UTIs by counting the bacteria in the urine specimen. With the improved 
counting precision over visual counting methods, highly accurate positive results 
can be obtained by this method. Detection of bacteriuria can be achieved with clini-
cal standards using flow cytometry technology [69, 70].
2.3.2 Test strip technology
Major improvement in the test strip technology has been made in recent years. 
Not only highly sensitive test strips are being introduced, but also now, one can find 
strips, which give quantitative results for urinary proteins. The financial aspect is also 
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of great importance, especially in the third world and developing countries; inexpen-
sive test strips for various diagnostic reasons such as the diagnosis of diabetes form 
urine sample are available [71, 72]. Test strip method also shows promising result in 
antibiotic susceptibility tests; if optimum diagnostic requirement is reached, it can 
reduce the test time significantly from 2 to 3 days to few hours. [73–75]
2.3.3 Automated microscopy
Urine microscopy is one of the most important diagnostic methods for UTIs 
and other kidney diseases. Manual microscopy is time-consuming and can be labor 
extensive. Furthermore, with centrifugation decantation and re-suspension always 
lead to cell loss and cellular lysis. With the current available digital microscopy 
technologies, a significant time reduction can be archived with much more sample 
being processed in significantly short time in comparison to manual microscopy. In 
addition, with the ability to process uncentrifuged urine sample, issues like cell loss 
and lysis are of no more concern. Many automated analyzers are now available in 
the market with different kinds of technologies such as laminar flow digital imaging 
technology and pattern recognition technology [65, 76, 77].
2.3.4 MALDI-TOF
The proteomic method “Matrix-assisted laser desorption ionization–time-of-
flight mass spectrometry (MALDI-TOF MS)” for identification of microorganisms 
directly from culture coupled with Gram stain has given new direction, saved con-
siderable amount of time in diagnosis of UTI, and contributed greatly in the field of 
clinical microbiology in general. It can identify different pathogens accurately and 
significantly in short time. The utilization of this technology for the diagnosis of 
UTIs and furthermore in preforming antibiotic susceptibility tests to decrease the 
testing time from days to as fast as 2 hours can open wide doors [78, 79].
2.3.5 Urinalysis and smartphones
Smartphone technologies improved the quality of life in countless fronts, and it 
has large potential for applications in the medical field. With point-of-care testing 
attracting much attention in recent years, smartphone solutions can be a valuable 
tool in this regard. It can, for example, increase the compliance of populations 
with screening programs by offering easy and fast screening method [80]. Studies 
exploring the possibility of establishing a smartphone-based diagnostic platform 
for rapid detection of Zika, chikungunya, and dengue viruses showed valuable 
prospective [20]. Several other smartphone applications utilizing urinalysis for 
various diagnostic reasons had been tested, and it shows promising future prospec-
tive which can greatly help both medical practitioners and patients alike [67, 81, 82].
3. Urine specimen and antibiotic-resistant pathogens
The emergence of the antimicrobial resistant pathogen is worldwide issue 
threatening thousands if not millions of lives every year and with more and more 
strains developing not only a single drug resistance but also multidrug resistance 
(MDR) making the treatment of the disease much more complicated. Furthermore, 
many pathogens have developed resistance against a second-line or even last resort 
drugs. Recently the emergence of colistin-resistant strains attracted a lot of atten-
tion. Some of these resistant pathogens can cause serious illness or even death. 
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Some Mycobacterium tuberculosis strains developed what is called extensively drug-
resistant (XDR), a rare form of MDR which shows resistance to at least one of the 
second-line drugs, isoniazid, rifampin, and fluoroquinolone [83, 84].
Enterobacteriaceae, the leading cause of UTIs, developed resistance to β-lactam 
antibiotics by producing β- Lactamases, rendering this class of antibiotic to a 








Amoxicillin 215 62.0 (55.5–68.9) 116 38.0 (31.1–44.5)
Amoxicillin/clavulanate 307 91.3 (87.9–94.6) 12 3.5 (1.5–5.5)
Cefuroxime 323 98.0 (96.4–99.7) 8 2.0 (0.3–3.6)
Cefotaxime 323 98.1 (96.5–99.7) 6 1.5 (0.1–3.0)
Ceftazidime 323 98.1 (96.5–99.7) 3 0.9 (0.0–2.1)
Carbapenems 331 100.0 0 0.0
Fosfomycin 331 100.0 0 0.0
Nitrofurantoin 328 99.6 (99.0–99.9) 3 0.4 (0.0–1.0)
Nalidixic acid 311 94.6 (92.1–97.1) 17 4.6 (0.2–7.1)
Ofloxacin 312 94.9 (92.6–97.3) 11 2.8 (1.1–4.4)
Ciprofloxacin 323 98.1 (96.5–99.7) 6 1.5 (0.1–3.0)
Aminoglycoside 327 98.7 (97.0–99.9) 4 1.3 (0.0–3.0)
Trimethoprim/sulfamethoxazole 278 81.9 (75.9–88.0) 51 17.8 (11.7–24.0)
*Estimated proportion with the sampling design and 95% CI.
n size in the study population.
Table 1. 
Resistance rates among 331 Escherichia coli from urinary tract infection of women over 18 visiting a French GP 
in 2012–2013 [85].
Figure 1. 
Schematic demonstrating how antibiotics can contribute to the AMR crisis and how it can change the 
microbiome of the patient.
9Urine Tests for Diagnosis of Infectious Diseases and Antibiotic-Resistant Pathogens
DOI: http://dx.doi.org/10.5772/intechopen.89231
development and only few new drugs being in the production pipeline, UTIs with 
AMR are a major concern, and it is a leading cause of morbidity and a cause of 
significant financial loss in many countries. It is estimated that 50% of all women 
will suffer from UTI at some point in their lives.
The abuse and misuse of antimicrobial drugs are the leading causes of this 
worldwide issue. Controlling the prescription of antimicrobial drugs by practicing 
judicial drug prescription based on susceptibility testing is of paramount importance 
not only to control this fast-growing issue of AMR against currently used drugs in 
the market but to ensure lasting effectiveness of future treatment options and drugs. 
This cannot be achieved by the effort of the medical practitioner only, but it needs 
the active effort of policymakers, scientist, and the large community (Figure 1).
Urine specimen can play a major role in fighting against this crisis; urine cultures 
for the diagnosis of UTIs can be used for susceptibility testing, thus following anti-
microbial stewardship program recommendation. Urine specimen has the potential 
to be used for the same reason in other infectious diseases where the pathogen can 
be found in urine (Table 1).
4. Conclusion
Over the ages, urine proved to be an extremely valuable diagnostic specimen; 
today, it constitutes one of the most common samples processed in clinical and 
diagnostic laboratories. Its role in the diagnosis of a wide and diverse range of 
disorders cannot be argued against, ranging from drugs test and metabolic diseases 
identification to the diagnosis of STDs and lethal infectious disease. Its importance 
in antimicrobial resistance tests is also of great value, contributing to achieving the 
antimicrobial stewardship program recommendations.
With the advances in today’s technologies, urinalysis now has great potentials, and 
the merging of test strip technologies with smartphone technologies can lead to tre-
mendous changes in healthcare system and can deeply integrate point-of-care testing 
into the health system. Furthermore, advances in mass spectrometry can lead to great 
achievement not only in the diagnostic field by providing a much faster and accurate 
results, but it can also contribute greatly in the medical and biomedical research fields.
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